A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas-Reference-Cited by-同舟云学术

A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas

Published:2017-11-01 Issue:2 Volume:65 Page:e26832
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Kilburn Lindsay B.¹^ORCID,Kocak Mehmet²,Baxter Patricia³,Poussaint Tina Young⁴,Paulino Arnold C.⁵^ORCID,McIntyre Christine⁶,Lemenuel-Diot Annabelle⁷,Lopez-Diaz Christine⁸,Kun Larry⁹,Chintagumpala Murali³,Su Jack M.³,Broniscer Alberto¹⁰¹¹,Baker Justin N.¹⁰,Hwang Eugene I.¹,Fouladi Maryam¹²,Boyett James M.¹³,Blaney Susan M.³

Affiliation:

1. Center for Cancer and Blood Disorders; Children's National Medical Center; Washington District of Columbia

2. Department of Preventive Medicine; University of Tennessee Health Science Center; Memphis Tennessee

3. Texas Children's Cancer Center; Baylor College of Medicine; Houston Texas

4. Department of Radiology; Boston Children's Hospital; Harvard Medical School; Boston Massachusetts

5. Department of Radiation Oncology; MD Anderson Cancer Center; Houston Texas

6. Roche Innovation Center; Welwyn United Kingdom

7. Roche Innovation Center; Basel Switzerland

8. Hoffman-LaRoche; Nutley New Jersey

9. Department of Radiological Sciences; St. Jude Children's Research Hospital Memphis; Tennessee

10. Department of Oncology; St. Jude Children's Research Hospital; Memphis Tennessee

11. Department of Pediatrics; University of Tennessee Health Sciences Center; Memphis Tennessee

12. Division of Hematology/Oncology; Cincinnati Children's Hospital Medical Center; Cincinnati Ohio

13. Department of Biostatistics; Operations and Biostatistics Center for PBTC; St. Jude Children's Research Hospital; Memphis Tennessee

Funder

F. Hoffmann-La Roche

National Institutes of Health

National Cancer Institute

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.26832/fullpdf

Reference25 articles.

1. Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group.;Albright;Neurosurgery,1993

2. Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group.;Cohen;Neuro Oncol,2011

3. Children's Oncology Group's 2013 blueprint for research: central nervous system tumors;Gajjar;Pediatr Blood Cancer,2013

4. Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy: results of a United Kingdom phase II trial (CNS 2007 04).;Bailey;Eur J Cancer,2013

5. Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a children's oncology group phase 2 study;Bradley;Int J Radiat Oncol Biol Phys,2008

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Update on H3K27M-altered Diffuse Midline Glioma: Diagnostic and Therapeutic Challenges in Clinical Practice;Practical Radiation Oncology;2024-09

2. Brain Stem Glioma Recurrence: Exploring the Therapeutic Frontiers;Journal of Personalized Medicine;2024-08-25

3. METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors;European Journal of Cancer;2024-02

4. The Role of Reirradiation in Childhood Progressive Diffuse Intrinsic Pontine Glioma (DIPG): An Ongoing Challenge beyond Radiobiology;Brain Sciences;2023-10-11

5. Epidemiology, Diagnostic Strategies, and Therapeutic Advances in Diffuse Midline Glioma;Journal of Clinical Medicine;2023-08-12